Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.
Certis Oncology Solutions, led by Peter Ellman, President and CEO, is a life science technology company dedicated to realizing the promise of precision oncology. The company’s product is Oncology ...